Antiviral activity of plant juices and green tea against SARS-CoV-2 and influenza virus.
COVID-19
black chokeberry (Aronia melanocarpae)
elderberry (Sambucus nigra)
oral rinses
pomegranate (Punica granatum)
virus transmission
Journal
Phytotherapy research : PTR
ISSN: 1099-1573
Titre abrégé: Phytother Res
Pays: England
ID NLM: 8904486
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
revised:
07
02
2022
received:
04
11
2020
accepted:
10
02
2022
pubmed:
2
3
2022
medline:
25
5
2022
entrez:
1
3
2022
Statut:
ppublish
Résumé
Respiratory viruses pose a significant threat to global health. They initially infect the naso- and oropharyngeal regions, where they amplify, cause symptoms, and may also be transmitted to new hosts. Preventing initial infection or reducing viral loads upon infection might soothe symptoms, prevent dissemination into the lower airways, or transmission to the next individual. Several natural products have well-described direct antiviral activity or may ameliorate symptoms of respiratory infections. We thus analyzed the potential of plant-derived products to inactivate respiratory viral pathogens and determined the antiviral activity of black chokeberry (Aronia melanocarpae [Michx.] Elliott), elderberry (Sambucus nigra L.), and pomegranate (Punica granatum L.) juice, as well as green tea (Camellia sinensis [L.] Kuntze) on the infectivity of the surrogate-modified vaccinia virus Ankara, and the respiratory viruses severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A virus (IAV), and adenovirus Type 5. Black chokeberry and pomegranate juice, and green tea reduced SARS-CoV-2 and IAV titers by ≥80% or ≥99%. This suggests that oral rinsing with these products may reduce viral loads in the oral cavity which might prevent viral transmission.
Identifiants
pubmed: 35229364
doi: 10.1002/ptr.7431
pmc: PMC9111003
doi:
Substances chimiques
Antiviral Agents
0
Tea
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2109-2115Subventions
Organisme : German Cancer Aid (Deutsche Krebshilfe)
Informations de copyright
© 2022 John Wiley & Sons Ltd.
Références
Euro Surveill. 2021 Jan;26(3):
pubmed: 33478622
Front Chem. 2021 Apr 28;9:638187
pubmed: 33996744
Function (Oxf). 2020;1(1):zqaa002
pubmed: 33215159
N Engl J Med. 2020 May 28;382(22):2158-2160
pubmed: 32329972
Phytomedicine. 2021 May;85:153286
pubmed: 32741697
Molecules. 2021 Jun 11;26(12):
pubmed: 34208050
Elife. 2020 Apr 02;9:
pubmed: 32228860
J Altern Complement Med. 1995 Winter;1(4):361-9
pubmed: 9395631
Biochem Biophys Res Commun. 2013 Oct 11;440(1):14-9
pubmed: 24012672
Infection. 2021 Apr;49(2):305-311
pubmed: 33315181
Molecules. 2017 Aug 12;22(8):
pubmed: 28805687
J Int Med Res. 2004 Mar-Apr;32(2):132-40
pubmed: 15080016
Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):1257-65
pubmed: 22012658
Ind Crops Prod. 2021 Jul;165:113438
pubmed: 33753964
Eur Arch Otorhinolaryngol. 2021 Dec;278(12):5059-5067
pubmed: 34021807
Planta Med. 2020 Jul;86(10):659-664
pubmed: 32434254
Phytomedicine. 2009 Dec;16(12):1127-36
pubmed: 19586764
Phytother Res. 2022 May;36(5):2109-2115
pubmed: 35229364
Jpn J Infect Dis. 2021 Sep 22;74(5):421-423
pubmed: 33518628
Springerplus. 2016 Jun 29;5(1):914
pubmed: 27386358
Cell. 2020 Jul 23;182(2):429-446.e14
pubmed: 32526206
J Infect Dis. 2020 Sep 14;222(8):1289-1292
pubmed: 32726430
Evid Based Complement Alternat Med. 2020 Sep 16;2020:5630838
pubmed: 32963564
BMC Public Health. 2016 May 12;16:396
pubmed: 27175786
Adv Integr Med. 2020 Dec;7(4):240-246
pubmed: 32864330
J Dent Res. 2021 Feb;100(2):124-132
pubmed: 33089717
Cell Biosci. 2021 Aug 30;11(1):168
pubmed: 34461999
Antiviral Res. 2010 Oct;88(1):1-9
pubmed: 20637243